This content is machine translated From genome profiles to targeted therapies Advances in breast cancer therapy in the age of molecular diagnostics The treatment of breast cancer has undergone a profound transformation over the last two decades. While clinical-pathological parameters long formed the sole basis for therapy decisions, molecular diagnostics and personalized...…
View Post 4 min This content is machine translated Breast Cancer Improving treatment management: genetics in focus The genetics of breast cancer has become a fundamental aspect of treatment management. It influences screening, follow-up, prophylactic and therapeutic recommendations for women who carry a germinal breast cancer susceptibility…
View Post 3 min This content is machine translated Breast Cancer BRCA mutations and their consequences Breast carcinoma is the most common malignant tumor of the mammary gland. In particular, mutations of the BRCA genes significantly increase the risk of disease, which is why genetic testing…
View Post 9 min This content is machine translated Epithelial ovarian carcinoma Newer therapeutic concepts with longer disease-free survival Ovarian cancer is usually diagnosed at an advanced stage and has an unfavorable prognosis. Maximal cytoreductive surgery, if possible, is the first priority therapeutically and prognostically, followed by platinum-containing chemotherapy.…
View Post 7 min This content is machine translated Radical surgery as a treatment option Prophylactic mastectomy – for which patients is it an option? Prophylactic mastectomy reduces the risk of breast cancer by more than 95% in a healthy BRCA mutation carrier. However, intensified screening is a good alternative to surgery. For a diseased…
